On this page

JAKAFI XR

ruxolitinib · Tablet, Extended Release

Prescription NDA RLD
Informational index, not medical advice. Content is reproduced from public FDA and NLM data. Always confirm against the manufacturer's current prescribing information. Report adverse events to FDA MedWatch.

Overview

Brand name
JAKAFI XR
Generic name
ruxolitinib
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
NDA · NDA
Labeler
Incyte Corporation
Product type
Human Prescription Drug
DEA schedule
Not scheduled
Active ingredients
5
NDC product codes
5
Packages
5
Data completeness
60% of corroborating sources present

Active ingredients

Source: NDC Directory
Active ingredients and strengths as listed in the NDC Directory.
Ingredient Strength RxCUI Monograph
Ruxolitinib 11 mg/1 1193331 View
Ruxolitinib 22 mg/1 1193331 View
Ruxolitinib 33 mg/1 1193331 View
Ruxolitinib 44 mg/1 1193331 View
Ruxolitinib 55 mg/1 1193331 View

Forms, strengths and routes

Source: NDC Directory
Dosage form
Tablet, Extended Release
Route of administration
Oral
Presentations
10

Pharmacologic classes are listed in the class section below.

Pharmacologic class

Source: NDC Directory
Established pharmacologic classes (EPC), mechanisms of action (MoA), chemical structures (CS) and physiologic effects (PE).
Class Type Browse
Janus Kinase Inhibitor [EPC] EPC All 15 members
Janus Kinase Inhibitors [MoA] MoA All 15 members
Kinase Inhibitor [EPC] EPC All 89 members

Regulatory status

Source: Drugs@FDANDC Directory
Application number
217180
Application type
NDA · New Drug Application
Approval date
May 1, 2026
Sponsor
INCYTE CORP
Products on application
5
Submissions recorded
2
Products approved under application 217180.
Product Trade name Form Strength Ingredient Status TE Flags
217180-001 JAKAFI XR TABLET, EXTENDED RELEASE RUXOLITINIB PHOSPHATE Prescription — RLD
217180-002 JAKAFI XR TABLET, EXTENDED RELEASE RUXOLITINIB PHOSPHATE Prescription — RLD
217180-003 JAKAFI XR TABLET, EXTENDED RELEASE RUXOLITINIB PHOSPHATE Prescription — RLD
217180-004 JAKAFI XR TABLET, EXTENDED RELEASE RUXOLITINIB PHOSPHATE Prescription — RLD
217180-005 JAKAFI XR TABLET, EXTENDED RELEASE RUXOLITINIB PHOSPHATE Prescription — RLD RS

Therapeutic equivalence

Source: Orange Book
TE code
—
Reference Listed Drug
Yes
Reference Standard
Yes

Codes beginning with “A” indicate products the FDA considers therapeutically equivalent. Codes beginning with “B” indicate bioequivalence has not been established. See methodology.

Patents and exclusivity

Source: Orange Book
Patent listings submitted under 21 U.S.C. 355(b)(1) and (c)(2).
Patent Expires Product Substance Use code Submitted
9814722 December 12, 2026 001 No U-3226 May 28, 2026
9814722 December 12, 2026 001 No U-3230 May 28, 2026
9206187 December 12, 2026 001 No U-3227 May 28, 2026
9206187 December 12, 2026 001 No U-3228 May 28, 2026
9079912 December 12, 2026 001 No U-3227 May 28, 2026
9079912 December 12, 2026 001 No U-3228 May 28, 2026
9079912 December 12, 2026 001 No U-3230 May 28, 2026
9079912 December 12, 2026 001 No U-3226 May 28, 2026
11744832 December 12, 2026 001 No U-3226 May 28, 2026
11744832 December 12, 2026 001 No U-3230 May 28, 2026
8530485 December 12, 2026 001 No May 28, 2026
9814722 December 12, 2026 002 No U-3226 May 28, 2026
9814722 December 12, 2026 002 No U-3230 May 28, 2026
9206187 December 12, 2026 002 No U-3227 May 28, 2026
9206187 December 12, 2026 002 No U-3228 May 28, 2026
9079912 December 12, 2026 002 No U-3227 May 28, 2026
9079912 December 12, 2026 002 No U-3228 May 28, 2026
9079912 December 12, 2026 002 No U-3230 May 28, 2026
9079912 December 12, 2026 002 No U-3226 May 28, 2026
11744832 December 12, 2026 002 No U-3226 May 28, 2026
11744832 December 12, 2026 002 No U-3230 May 28, 2026
8530485 December 12, 2026 002 No May 28, 2026
9814722 December 12, 2026 003 No U-3226 May 28, 2026
9814722 December 12, 2026 003 No U-3230 May 28, 2026
9206187 December 12, 2026 003 No U-3227 May 28, 2026
9206187 December 12, 2026 003 No U-3228 May 28, 2026
9079912 December 12, 2026 003 No U-3227 May 28, 2026
9079912 December 12, 2026 003 No U-3228 May 28, 2026
9079912 December 12, 2026 003 No U-3230 May 28, 2026
9079912 December 12, 2026 003 No U-3226 May 28, 2026
11744832 December 12, 2026 003 No U-3226 May 28, 2026
11744832 December 12, 2026 003 No U-3230 May 28, 2026
8530485 December 12, 2026 003 No May 28, 2026
9814722 December 12, 2026 004 No U-3226 May 28, 2026
9814722 December 12, 2026 004 No U-3230 May 28, 2026
9206187 December 12, 2026 004 No U-3227 May 28, 2026
9206187 December 12, 2026 004 No U-3228 May 28, 2026
9079912 December 12, 2026 004 No U-3227 May 28, 2026
9079912 December 12, 2026 004 No U-3228 May 28, 2026
9079912 December 12, 2026 004 No U-3230 May 28, 2026
9079912 December 12, 2026 004 No U-3226 May 28, 2026
11744832 December 12, 2026 004 No U-3226 May 28, 2026
11744832 December 12, 2026 004 No U-3230 May 28, 2026
8530485 December 12, 2026 004 No May 28, 2026
9814722 December 12, 2026 005 No U-3226 May 28, 2026
9814722 December 12, 2026 005 No U-3230 May 28, 2026
9206187 December 12, 2026 005 No U-3227 May 28, 2026
9206187 December 12, 2026 005 No U-3228 May 28, 2026
9079912 December 12, 2026 005 No U-3227 May 28, 2026
9079912 December 12, 2026 005 No U-3228 May 28, 2026
9079912 December 12, 2026 005 No U-3230 May 28, 2026
9079912 December 12, 2026 005 No U-3226 May 28, 2026
11744832 December 12, 2026 005 No U-3226 May 28, 2026
11744832 December 12, 2026 005 No U-3230 May 28, 2026
8530485 December 12, 2026 005 No May 28, 2026
7598257 December 24, 2027 001 Yes U-3227 May 28, 2026
7598257 December 24, 2027 001 Yes U-3228 May 28, 2026
8415362 December 24, 2027 001 Yes May 28, 2026
7598257 December 24, 2027 002 Yes U-3227 May 28, 2026
7598257 December 24, 2027 002 Yes U-3228 May 28, 2026
8415362 December 24, 2027 002 Yes May 28, 2026
7598257 December 24, 2027 003 Yes U-3227 May 28, 2026
7598257 December 24, 2027 003 Yes U-3228 May 28, 2026
8415362 December 24, 2027 003 Yes May 28, 2026
7598257 December 24, 2027 004 Yes U-3227 May 28, 2026
7598257 December 24, 2027 004 Yes U-3228 May 28, 2026
8415362 December 24, 2027 004 Yes May 28, 2026
7598257 December 24, 2027 005 Yes U-3227 May 28, 2026
7598257 December 24, 2027 005 Yes U-3228 May 28, 2026
8415362 December 24, 2027 005 Yes May 28, 2026
8829013 June 12, 2028 001 No U-3227 May 28, 2026
8829013 June 12, 2028 001 No U-3228 May 28, 2026
10016429 June 12, 2028 001 No U-3226 May 28, 2026
10016429 June 12, 2028 001 No U-3230 May 28, 2026
8822481 June 12, 2028 001 No U-3227 May 28, 2026
8822481 June 12, 2028 001 No U-3228 May 28, 2026
8822481 June 12, 2028 001 No U-3230 May 28, 2026
8822481 June 12, 2028 001 No U-3226 May 28, 2026
8722693 June 12, 2028 001 Yes May 28, 2026
11213528 June 12, 2028 001 No May 28, 2026
8829013 June 12, 2028 002 No U-3227 May 28, 2026
8829013 June 12, 2028 002 No U-3228 May 28, 2026
10016429 June 12, 2028 002 No U-3226 May 28, 2026
10016429 June 12, 2028 002 No U-3230 May 28, 2026
8822481 June 12, 2028 002 No U-3227 May 28, 2026
8822481 June 12, 2028 002 No U-3228 May 28, 2026
8822481 June 12, 2028 002 No U-3230 May 28, 2026
8822481 June 12, 2028 002 No U-3226 May 28, 2026
8722693 June 12, 2028 002 Yes May 28, 2026
11213528 June 12, 2028 002 No May 28, 2026
8829013 June 12, 2028 003 No U-3227 May 28, 2026
8829013 June 12, 2028 003 No U-3228 May 28, 2026
10016429 June 12, 2028 003 No U-3226 May 28, 2026
10016429 June 12, 2028 003 No U-3230 May 28, 2026
8822481 June 12, 2028 003 No U-3227 May 28, 2026
8822481 June 12, 2028 003 No U-3228 May 28, 2026
8822481 June 12, 2028 003 No U-3230 May 28, 2026
8822481 June 12, 2028 003 No U-3226 May 28, 2026
11213528 June 12, 2028 003 No May 28, 2026
8722693 June 12, 2028 003 Yes May 28, 2026
8829013 June 12, 2028 004 No U-3227 May 28, 2026
8829013 June 12, 2028 004 No U-3228 May 28, 2026
10016429 June 12, 2028 004 No U-3226 May 28, 2026
10016429 June 12, 2028 004 No U-3230 May 28, 2026
8822481 June 12, 2028 004 No U-3227 May 28, 2026
8822481 June 12, 2028 004 No U-3228 May 28, 2026
8822481 June 12, 2028 004 No U-3230 May 28, 2026
8822481 June 12, 2028 004 No U-3226 May 28, 2026
11213528 June 12, 2028 004 No May 28, 2026
8722693 June 12, 2028 004 Yes May 28, 2026
8829013 June 12, 2028 005 No U-3227 May 28, 2026
8829013 June 12, 2028 005 No U-3228 May 28, 2026
10016429 June 12, 2028 005 No U-3226 May 28, 2026
10016429 June 12, 2028 005 No U-3230 May 28, 2026
8822481 June 12, 2028 005 No U-3227 May 28, 2026
8822481 June 12, 2028 005 No U-3228 May 28, 2026
8822481 June 12, 2028 005 No U-3230 May 28, 2026
8822481 June 12, 2028 005 No U-3226 May 28, 2026
8722693 June 12, 2028 005 Yes May 28, 2026
11213528 June 12, 2028 005 No May 28, 2026
8415362*PED June 24, 2028 001 No —
7598257*PED June 24, 2028 001 No —
8415362*PED June 24, 2028 002 No —
7598257*PED June 24, 2028 002 No —
8415362*PED June 24, 2028 003 No —
7598257*PED June 24, 2028 003 No —
8415362*PED June 24, 2028 004 No —
7598257*PED June 24, 2028 004 No —
8415362*PED June 24, 2028 005 No —
7598257*PED June 24, 2028 005 No —
8829013*PED December 12, 2028 001 No —
10016429*PED December 12, 2028 001 No —
8822481*PED December 12, 2028 001 No —
11213528*PED December 12, 2028 001 No —
8722693*PED December 12, 2028 001 No —
8829013*PED December 12, 2028 002 No —
10016429*PED December 12, 2028 002 No —
8822481*PED December 12, 2028 002 No —
11213528*PED December 12, 2028 002 No —
8722693*PED December 12, 2028 002 No —
8829013*PED December 12, 2028 003 No —
10016429*PED December 12, 2028 003 No —
8822481*PED December 12, 2028 003 No —
11213528*PED December 12, 2028 003 No —
8722693*PED December 12, 2028 003 No —
8829013*PED December 12, 2028 004 No —
10016429*PED December 12, 2028 004 No —
8822481*PED December 12, 2028 004 No —
11213528*PED December 12, 2028 004 No —
8722693*PED December 12, 2028 004 No —
8829013*PED December 12, 2028 005 No —
10016429*PED December 12, 2028 005 No —
8822481*PED December 12, 2028 005 No —
11213528*PED December 12, 2028 005 No —
8722693*PED December 12, 2028 005 No —
11576864 November 14, 2033 001 No U-3227 May 28, 2026
11576864 November 14, 2033 001 No U-3228 May 28, 2026
11576864 November 14, 2033 001 No U-3230 May 28, 2026
11576864 November 14, 2033 001 No U-3226 May 28, 2026
11896717 November 14, 2033 001 No U-3227 May 28, 2026
11896717 November 14, 2033 001 No U-3228 May 28, 2026
11896717 November 14, 2033 001 No U-3230 May 28, 2026
11896717 November 14, 2033 001 No U-3226 May 28, 2026
11576865 November 14, 2033 001 No U-3227 May 28, 2026
11576865 November 14, 2033 001 No U-3228 May 28, 2026
11576865 November 14, 2033 001 No U-3230 May 28, 2026
11576865 November 14, 2033 001 No U-3226 May 28, 2026
10874616 November 14, 2033 001 No May 28, 2026
11576864 November 14, 2033 002 No U-3227 May 28, 2026
11576864 November 14, 2033 002 No U-3228 May 28, 2026
11576864 November 14, 2033 002 No U-3230 May 28, 2026
11576864 November 14, 2033 002 No U-3226 May 28, 2026
11896717 November 14, 2033 002 No U-3227 May 28, 2026
11896717 November 14, 2033 002 No U-3228 May 28, 2026
11896717 November 14, 2033 002 No U-3230 May 28, 2026
11896717 November 14, 2033 002 No U-3226 May 28, 2026
11576865 November 14, 2033 002 No U-3227 May 28, 2026
11576865 November 14, 2033 002 No U-3228 May 28, 2026
11576865 November 14, 2033 002 No U-3230 May 28, 2026
11576865 November 14, 2033 002 No U-3226 May 28, 2026
10874616 November 14, 2033 002 No May 28, 2026
11576864 November 14, 2033 003 No U-3227 May 28, 2026
11576864 November 14, 2033 003 No U-3228 May 28, 2026
11576864 November 14, 2033 003 No U-3230 May 28, 2026
11576864 November 14, 2033 003 No U-3226 May 28, 2026
11896717 November 14, 2033 003 No U-3227 May 28, 2026
11896717 November 14, 2033 003 No U-3228 May 28, 2026
11896717 November 14, 2033 003 No U-3230 May 28, 2026
11896717 November 14, 2033 003 No U-3226 May 28, 2026
11576865 November 14, 2033 003 No U-3227 May 28, 2026
11576865 November 14, 2033 003 No U-3228 May 28, 2026
11576865 November 14, 2033 003 No U-3230 May 28, 2026
11576865 November 14, 2033 003 No U-3226 May 28, 2026
10874616 November 14, 2033 003 No May 28, 2026
11576864 November 14, 2033 004 No U-3227 May 28, 2026
11576864 November 14, 2033 004 No U-3228 May 28, 2026
11576864 November 14, 2033 004 No U-3230 May 28, 2026
11576864 November 14, 2033 004 No U-3226 May 28, 2026
11896717 November 14, 2033 004 No U-3227 May 28, 2026
11896717 November 14, 2033 004 No U-3228 May 28, 2026
11896717 November 14, 2033 004 No U-3230 May 28, 2026
11896717 November 14, 2033 004 No U-3226 May 28, 2026
11576865 November 14, 2033 004 No U-3227 May 28, 2026
11576865 November 14, 2033 004 No U-3228 May 28, 2026
11576865 November 14, 2033 004 No U-3230 May 28, 2026
11576865 November 14, 2033 004 No U-3226 May 28, 2026
10874616 November 14, 2033 004 No May 28, 2026
11576864 November 14, 2033 005 No U-3227 May 28, 2026
11576864 November 14, 2033 005 No U-3228 May 28, 2026
11576864 November 14, 2033 005 No U-3230 May 28, 2026
11576864 November 14, 2033 005 No U-3226 May 28, 2026
11896717 November 14, 2033 005 No U-3227 May 28, 2026
11896717 November 14, 2033 005 No U-3228 May 28, 2026
11896717 November 14, 2033 005 No U-3230 May 28, 2026
11896717 November 14, 2033 005 No U-3226 May 28, 2026
11576865 November 14, 2033 005 No U-3227 May 28, 2026
11576865 November 14, 2033 005 No U-3228 May 28, 2026
11576865 November 14, 2033 005 No U-3230 May 28, 2026
11576865 November 14, 2033 005 No U-3226 May 28, 2026
10874616 November 14, 2033 005 No May 28, 2026
11337927 January 17, 2034 001 No U-3227 May 28, 2026
11337927 January 17, 2034 001 No U-3228 May 28, 2026
11337927 January 17, 2034 001 No U-3230 May 28, 2026
11337927 January 17, 2034 001 No U-3226 May 28, 2026
11337927 January 17, 2034 002 No U-3227 May 28, 2026
11337927 January 17, 2034 002 No U-3228 May 28, 2026
11337927 January 17, 2034 002 No U-3230 May 28, 2026
11337927 January 17, 2034 002 No U-3226 May 28, 2026
11337927 January 17, 2034 003 No U-3227 May 28, 2026
11337927 January 17, 2034 003 No U-3228 May 28, 2026
11337927 January 17, 2034 003 No U-3230 May 28, 2026
11337927 January 17, 2034 003 No U-3226 May 28, 2026
11337927 January 17, 2034 004 No U-3227 May 28, 2026
11337927 January 17, 2034 004 No U-3228 May 28, 2026
11337927 January 17, 2034 004 No U-3230 May 28, 2026
11337927 January 17, 2034 004 No U-3226 May 28, 2026
11337927 January 17, 2034 005 No U-3227 May 28, 2026
11337927 January 17, 2034 005 No U-3228 May 28, 2026
11337927 January 17, 2034 005 No U-3230 May 28, 2026
11337927 January 17, 2034 005 No U-3226 May 28, 2026
10874616*PED May 14, 2034 001 No —
11576864*PED May 14, 2034 001 No —
11896717*PED May 14, 2034 001 No —
11576865*PED May 14, 2034 001 No —
10874616*PED May 14, 2034 002 No —
11576864*PED May 14, 2034 002 No —
11896717*PED May 14, 2034 002 No —
11576865*PED May 14, 2034 002 No —
10874616*PED May 14, 2034 003 No —
11576864*PED May 14, 2034 003 No —
11896717*PED May 14, 2034 003 No —
11576865*PED May 14, 2034 003 No —
10874616*PED May 14, 2034 004 No —
11576864*PED May 14, 2034 004 No —
11896717*PED May 14, 2034 004 No —
11576865*PED May 14, 2034 004 No —
10874616*PED May 14, 2034 005 No —
11576864*PED May 14, 2034 005 No —
11896717*PED May 14, 2034 005 No —
11576865*PED May 14, 2034 005 No —
11337927*PED July 17, 2034 001 No —
11337927*PED July 17, 2034 002 No —
11337927*PED July 17, 2034 003 No —
11337927*PED July 17, 2034 004 No —
11337927*PED July 17, 2034 005 No —
Regulatory exclusivity periods.
Code Expires Product
ODE* September 22, 2028 001
ODE* September 22, 2028 002
ODE* September 22, 2028 003
ODE* September 22, 2028 004
ODE* September 22, 2028 005
PED March 22, 2029 001
PED March 22, 2029 002
PED March 22, 2029 003
PED March 22, 2029 004
PED March 22, 2029 005

Approval history

Source: Drugs@FDA
Most recent submissions on application 217180.
Type No. Action Status Date Review
Supplement 1 Labeling Approved July 20, 2026 Standard
Original application 1 Type 5 - New Formulation or New Manufacturer Approved May 1, 2026 Standard

Review documents

  • 0 · Supplement · July 30, 2026
  • 0 · Supplement · July 22, 2026
  • 0 · Original application · May 5, 2026
  • 0 · Original application · May 4, 2026

Adverse event reports

Source: openFDA FAERS
71,241
FAERS reports mentioning this drug
as of 2026-09-25T03:42:24+00:00
A report count is not a risk measure. FAERS accepts voluntary and mandatory reports without establishing causation, and reporting is influenced by how widely a drug is used, how long it has been marketed, and media attention. FDA states that reports “do not prove that the drug caused the event”. Compare rates, not totals.

Attributed to this product's most-reported active ingredient: RUXOLITINIB. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.

Packaging and NDCs

Source: NDC Directory
Every National Drug Code package associated with this medication. The NDC is the identifier used for dispensing, billing and pharmacovigilance in the United States.
Package NDC Product NDC Labeler Description Marketing start
50881-011-08 50881-011 Incyte Corporation 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-011-08) May 1, 2026
50881-022-08 50881-022 Incyte Corporation 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-022-08) May 1, 2026
50881-033-08 50881-033 Incyte Corporation 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-033-08) May 1, 2026
50881-044-08 50881-044 Incyte Corporation 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-044-08) May 1, 2026
50881-055-08 50881-055 Incyte Corporation 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-055-08) May 1, 2026
50881-011 50881-011 Incyte Corporation — May 1, 2026
50881-022 50881-022 Incyte Corporation — May 1, 2026
50881-033 50881-033 Incyte Corporation — May 1, 2026
50881-044 50881-044 Incyte Corporation — May 1, 2026
50881-055 50881-055 Incyte Corporation — May 1, 2026

Sources for this page

Every dataset that contributed a fact to this page.
Dataset Agency Used for
NDC Directory FDA Identity, ingredients, strengths, forms, routes, labelers, packages
Drugs@FDA FDA Application, sponsor, submissions, review documents, marketing status
Orange Book FDA Therapeutic equivalence codes, reference drug flags, patents, exclusivity
FAERS FDA Adverse event report counts

Generated September 25, 2026 · 11 sections on this page.